Fortress Biotech Stock Technical Analysis

FBIO Stock  USD 3.09  0.06  1.90%   
As of the 4th of February, Fortress Biotech shows the Downside Deviation of 4.55, coefficient of variation of 1080.59, and Mean Deviation of 3.2. Fortress Biotech technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Fortress Biotech Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Fortress, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to FortressFortress Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Fortress Biotech Analyst Consensus

Target PriceConsensus# of Analysts
10.75Strong Buy2Odds
Fortress Biotech current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Fortress analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Fortress stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Fortress Biotech, talking to its executives and customers, or listening to Fortress conference calls.
Fortress Analyst Advice Details
Will Biotechnology sector continue expanding? Could Fortress diversify its offerings? Factors like these will boost the valuation of Fortress Biotech. Market participants price Fortress higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fortress Biotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.12)
Revenue Per Share
2.324
Quarterly Revenue Growth
0.205
Return On Assets
(0.34)
Return On Equity
(2.05)
Fortress Biotech's market price often diverges from its book value, the accounting figure shown on Fortress's balance sheet. Smart investors calculate Fortress Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Fortress Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Fortress Biotech 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fortress Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fortress Biotech.
0.00
11/06/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/04/2026
0.00
If you would invest  0.00  in Fortress Biotech on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Fortress Biotech or generate 0.0% return on investment in Fortress Biotech over 90 days. Fortress Biotech is related to or competes with XBiotech, Nutriband, Vaxart, CervoMed, Adagene, Relmada Therapeutics, and Gain Therapeutics. Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology produc... More

Fortress Biotech Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fortress Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fortress Biotech upside and downside potential and time the market with a certain degree of confidence.

Fortress Biotech Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Fortress Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fortress Biotech's standard deviation. In reality, there are many statistical measures that can use Fortress Biotech historical prices to predict the future Fortress Biotech's volatility.
Hype
Prediction
LowEstimatedHigh
0.153.097.59
Details
Intrinsic
Valuation
LowRealHigh
0.163.267.76
Details
Naive
Forecast
LowNextHigh
0.063.207.70
Details
2 Analysts
Consensus
LowTargetHigh
9.7810.7511.93
Details

Fortress Biotech February 4, 2026 Technical Indicators

Fortress Biotech Backtested Returns

Fortress Biotech appears to be risky, given 3 months investment horizon. Fortress Biotech secures Sharpe Ratio (or Efficiency) of 0.0977, which denotes the company had a 0.0977 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Fortress Biotech, which you can use to evaluate the volatility of the firm. Please utilize Fortress Biotech's Mean Deviation of 3.2, downside deviation of 4.55, and Coefficient Of Variation of 1080.59 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Fortress Biotech holds a performance score of 7. The firm shows a Beta (market volatility) of 1.88, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fortress Biotech will likely underperform. Please check Fortress Biotech's semi variance, and the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Fortress Biotech's price patterns will revert.

Auto-correlation

    
  -0.68  

Very good reverse predictability

Fortress Biotech has very good reverse predictability. Overlapping area represents the amount of predictability between Fortress Biotech time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fortress Biotech price movement. The serial correlation of -0.68 indicates that around 68.0% of current Fortress Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient-0.68
Spearman Rank Test-0.52
Residual Average0.0
Price Variance0.14
Fortress Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Fortress Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Fortress Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Fortress Biotech Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Fortress Biotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Fortress Biotech Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Fortress Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Fortress Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Fortress Biotech price pattern first instead of the macroeconomic environment surrounding Fortress Biotech. By analyzing Fortress Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Fortress Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Fortress Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2025 2026 (projected)
Dividend Yield0.360.110.10.0776
Price To Sales Ratio0.290.730.840.8

Fortress Biotech February 4, 2026 Technical Indicators

Most technical analysis of Fortress help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Fortress from various momentum indicators to cycle indicators. When you analyze Fortress charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Fortress Biotech February 4, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Fortress stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Fortress Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fortress Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fortress Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fortress Biotech Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Will Biotechnology sector continue expanding? Could Fortress diversify its offerings? Factors like these will boost the valuation of Fortress Biotech. Market participants price Fortress higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fortress Biotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.12)
Revenue Per Share
2.324
Quarterly Revenue Growth
0.205
Return On Assets
(0.34)
Return On Equity
(2.05)
Fortress Biotech's market price often diverges from its book value, the accounting figure shown on Fortress's balance sheet. Smart investors calculate Fortress Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Fortress Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.